9,10-dimethyl-1,2-benzanthracene and Adverse Drug Event

9,10-dimethyl-1,2-benzanthracene has been researched along with Adverse Drug Event in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Espandiari, P; Hanig, JP; Honchel, R; Knapton, A; Miller, TJ; Sistare, FD; Zhang, J	1

Other Studies

1 other study(ies) available for 9,10-dimethyl-1,2-benzanthracene and Adverse Drug Event

Article	Year
The utility of the K6/ODC transgenic mouse as an alternative short term dermal model for carcinogenicity testing of pharmaceuticals. Regulatory toxicology and pharmacology : RTP, 2008, Volume: 50, Issue:1 Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Carcinogenicity Tests; Carcinogens; Disease Models, Animal; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Keratin-6; Kidney; Liver; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Ornithine Decarboxylase; Sarcoma Viruses, Murine; Skin Neoplasms; Spleen; Transfection	2008

Article

Year

The utility of the K6/ODC transgenic mouse as an alternative short term dermal model for carcinogenicity testing of pharmaceuticals.

Regulatory toxicology and pharmacology : RTP, 2008, Volume: 50, Issue:1

Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Carcinogenicity Tests; Carcinogens; Disease Models, Animal; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Keratin-6; Kidney; Liver; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Ornithine Decarboxylase; Sarcoma Viruses, Murine; Skin Neoplasms; Spleen; Transfection

2008